Patents by Inventor Katherine Macfarlane

Katherine Macfarlane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclic pyrimidinones and uses thereof
    Patent number: 8859563
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. A pharmaceutical composition or medicament comprising a compound of Formula I is also provided.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: October 14, 2014
    Assignee: Avexa Limited
    Inventors: Eric Dale Jones, Jonathan Alan Victor Coates, David Ian Rhodes, John Joseph Deadman, Nicholas Andrew Van de Graff, Lisa Jane Winfield, Neeranat Thienthong, William Issa, Neil Choi, Katherine Macfarlane
  • Bicyclic pyrimidinones and uses thereof
    Publication number: 20120232035
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. A pharmaceutical composition or medicament comprising a compound of Formula I is also provided.
    Type: Application
    Filed: February 27, 2012
    Publication date: September 13, 2012
    Applicant: AVEXA LIMITED
    Inventors: Eric Dale Jones, Jonathan Alan Victor Coates, David Ian Rhodes, John Joseph Deadman, Nicholas Andrew Vandegraff, Lisa Jane Winfield, Neeranat Thienthong, William Issa, Neil Choi, Katherine Macfarlane
  • Bicyclic pyrimidinones and uses thereof
    Patent number: 8143268
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. A pharmaceutical composition or medicament comprising a compound of Formula I is also provided.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: March 27, 2012
    Assignee: Avexa Limited
    Inventors: Eric Dale Jones, Jonathan Alan Victor Coates, David Ian Rhodes, John Joseph Deadman, Nicholas Andrew Vandegraff, Lisa Jane Winfield, Neeranat Thienthong, William Issa, Neil Choi, Katherine Macfarlane
  • BICYCLIC PYRIMIDINONES AND USES THEREOF
    Publication number: 20100168063
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. A pharmaceutical composition or medicament comprising a compound of Formula I is also provided.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 1, 2010
    Applicant: Avexa Limited
    Inventors: Eric Dale Jones, Jonathan Alan Coates, David Ian Rhodes, John Joseph Deadman, Nicholas Andrew Vandegraff, Lisa Jane Winfield, Neeranat Thienthong, William Issa, Neil Choi, Katherine MacFarlane
  • Integrase Inhibitors 3
    Publication number: 20100009973
    Abstract: The present invention provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Compounds of formula (I) are also provided.
    Type: Application
    Filed: April 30, 2007
    Publication date: January 14, 2010
    Applicant: AVEXA LIMITED
    Inventors: David Ian Rhodes, Katherine MacFarlane, Eric Dale Jones, William Issa, John Joseph Deadman, Neil Choi
  • Agents and methods for the treatment of disorders associated with oxidative stress
    Publication number: 20050288359
    Abstract: The invention provides a method for preventing or reducing the effects of oxidative stress on a substrate. The method includes the step of treating the substrate with a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein: R1 is one or more substituents selected from —H, -alkyl, -alkoxy, -aryl, -aryloxy, -halogen, -amino (mono-, di- and tri-substituted), -alkylthio, —NO2, —COOH, —COOAlkyl, —CO-alkyl, —CN; R2 is one or more substituents selected from —H, -alkyl, —(CH2CH2O)n-R5, a sugar moiety; R3 is —H, -alkyl, -aryl, -alkylOR6, -alkylC(O)R6; R5 is selected from —H, -alkyl, -aryl; and R4 and R6 are independently selected from —OH, —O-alkyl, —O-polyalkyleneoxy, —O-aryl, —OC(O)O-alkyl, —S-alkyl and -amino.
    Type: Application
    Filed: May 27, 2003
    Publication date: December 29, 2005
    Applicant: Monash University
    Inventors: Surindar Cheema, Steven Langford, Nam Cheung, Philip Beart, Katherine Macfarlane, Mark Mulcair